TribLIVE

| USWorld

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Bayer, Reckitt among final contenders for Merck consumer health care unit

Email Newsletters

Click here to sign up for one of our email newsletters.

Daily Photo Galleries

By Reuters
Saturday, April 26, 2014, 8:57 p.m.
 

Merck & Co. Inc. is in the final stages of selling its consumer health care unit for nearly $14 billion, with Bayer AG and Reckitt Benckiser Group Plc among final contenders to clinch a deal as soon as this week, people familiar with the matter said.

Germany's Bayer and British consumer products giant Reckitt have emerged as front-runners to win the auction after each offering about $13.5 billion for the Merck consumer unit, best known for Coppertone sunscreen and Claritin allergy medicine, the sources said.

Both bidders are very keen to buy the asset, and the price tag could go higher in the final days, one person added. All the people asked not to be named because the matter is not public.

Representatives of American drugmaker Merck, as well as Bayer and Reckitt, declined to comment.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. 1 Marine killed, 9 hurt in helicopter hard landing
  2. U.S. Catholics at odds with church, survey finds
  3. World population of trees to people: 422 to 1, team finds
  4. Army fully opens Ranger School to female soldiers
  5. 34th senator signs on to Iran nuclear deal, crumbling GOP’s hopes to override veto
  6. Judge clears way for revival of NSA wiretap suit
  7. Sasquatch sighting! Maine police say Bigfoot artist nabbed
  8. Financial exec gets 8 years for fraud
  9. Clinton: Women ‘expect’ extremism from terrorists, not GOP candidates
  10. West Point law professor resigns amid remarks that critics of war on terror are ‘treasonous’
  11. Baltimore officers on track for trial